Mersana Therapeutics Inc (MRSN)
NASDAQ:MRSN
Holding MRSN?
Track your performance easily

Mersana Therapeutics (MRSN) Cash flow

435 Followers

Mersana Therapeutics Cash Flow

MRSN's free cash flow for Q2 2024 was $-21.86M. For the 2024 fiscal year, MRSN's free cash flow was decreased by $-119.49M and operating cash flow was $-21.86M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -132.56M$ -168.88M$ -49.36M$ -139.99M$ -74.70M$ -67.74M
Investing Cash Flow
$ 56.89M$ 119.88M$ -152.72M$ -648.00K$ 37.03M$ -27.29M
Financing Cash Flow
$ 5.93M$ 94.67M$ 153.02M$ 63.65M$ 230.41M$ 97.70M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 451.26M$ 129.36M$ 129.36M$ 178.43M$ 62.67M$ 60.01M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 3.49M$ 3.38M$ 2.46M$ 429.00K$ 234.00K$ 132.00K
Issuance Of Capital Stock
$ 5.70M----$ 92.16M
Issuance Of Debt
$ -93.00K$ -262.00K$ -272.00K$ -5.70M$ -116.00K$ -87.00K
Repayment Of Debt
$ -93.00K$ -262.00K$ -272.00K$ -5.70M$ -116.00K$ -87.00K
Free Cash Flow
$ -133.54M$ -171.05M$ -51.56M$ -140.64M$ -75.17M$ -68.35M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Mersana Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis